Author:
Shirey K A,Pletneva L M,Puche A C,Keegan A D,Prince G A,Blanco J C G,Vogel S N
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy
Reference47 articles.
1. Welliver, R.C. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. J. Pediatr. 143, S112–117 (2003).
2. Blanco, J.C.G., Boukhvalova, M., Pletneva, L., Prince, G.A. & Vogel, S.N. Re-thinking respiratory syncytial virus vaccines. Recent Res. Develop. Exp. Med. 1, 75–94. Appendix 1 (2004).
3. Boukhvalova, M.S., Prince, G.A., Soroush, L., Harrigan, D.C., Vogel, S.N. & Blanco, J.C. The TLR4 agonist, monophosphoryl lipid A, attenuates the cytokine storm associated with respiratory syncytial virus vaccine-enhanced disease. Vaccine 24, 5027–5035 (2006).
4. Pletneva, L.M., Haller, O., Porter, D.D., Prince, G.A. & Blanco, J.C. Interferon-inducible Mx gene expression in cotton rats: cloning, characterization, and expression during influenza viral infection. J. Interferon Cytokine Res. 26, 914–921 (2006).
5. Kurt-Jones, E.A. et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1, 398–401 (2000).
Cited by
176 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献